Chronic administration of quinolinic acid in the rat striatum causes spatial learning deficits in a radial arm water maze task

Experimental Neurology

Volumn 150, Issue 2, 1998, Pages 305-311

  Shear, Deborah A ^a   Dong, Jie ^a   Haik Creguer, Kristi L ^a   Bazzett, Terence J ^b   Albin, Roger L ^c,d   Dunbar, Gary L ^a  

^a CENTRAL MICHIGAN UNIVERSITY   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Dialytic apparatus; Huntington's disease; Neostriatum; Quinolinic acid; Reference memory errors; Spatial learning; Working memory errors

Indexed keywords

QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPTH PERCEPTION; HISTOLOGY; HUNTINGTON CHOREA; LEARNING DISORDER; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SWIMMING; WORKING MEMORY;

EID: 0032051772     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6767     Document Type: Article

References (30)

1. Bazzett T. J., Becker J. B., Albin R. L. A novel device for chronic intracranial drug delivery via microdialysis. J. Neurosci. Methods. 40:1991;1-8.
2. Bazzett T. J., Becker J. B., Kaatz K. W., Albin R. L. Chronic intrastriatal dialytic administration of quinolinic acid produces selective neurodegeneration. Exp. Neurol. 120:1993;177-185.
3. Bazzett T. J., Becker J. B., Falik R. C., Albin R. L. Chronic intrastriatal quinolinic acid produces reversible changes in perikaryal calbindin and parvalbumin immunoreactivity. Neuroscience. 60:1994;837-841.
4. Bazzett T. J., Falik R. C., Becker J. B., Albin R. L. Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat. Brain Res. 39:1996;69-73.
5. Beal M. F., Kowall N. W., Ellison D. W., Mazurek M. F., Swartz K. J., Martin J. B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature. 321:1986;168-171.
6. Block F., Kunkel M., Schwarz M. Quinolinic acid lesion of the striatum induces impairment in spatial learning and motor performance in rats. Neurosci. Lett. 149:1993;126-128.
7. Bureš J., Burešová O., Huston J. Techniques and Basic Experiments for the Study of Brain and Behavior. 1976;Elsevier Scientific Publishing Company/North Holland Biomedical Press.
8. Burešová O., Bureš J., Oitzl M. S., Zahalka A. Radial maze in the water tank: An aversively motivated spatial working memory task. Physiol. Behav. 34:1985;1003-1005.
9. Butters N., Salmon D., Heindel W. C. Specificity of the memory deficits associated with basal ganglia dysfunction. Rev. Neurol. 150:1994;580-587.
10. Curtis C. L., Ross G. J. III, Hyde E. A., Szymanski R. E., Hull J. S., Dunbar G. L. Intrastriatal injections of quinolinic acid causes spatial learning deficits in rats. Soc. Neurosci. Abstr. 18:1992;1602.
11. Diamond R., White R. F., Myers R. H., Mastromauro C., Koroshetz W. J., Butters N., Rothstein D. M., Moss M. B., Vasterling J. Evidence of presymptomatic cognitive decline in Huntington's disease. J. Clin. Exp. Neuropsychol. 14:1992;961-975.
12. Emerich D. F., Cain C. K., Greco C., Saydoff J. A., Hu Z. Y., Liu H., Lindner M. D. Cellular delivery of human CNTF prevents motor and cognitive dysfunction in a rodent model of Huntington's disease. Cell Transplant. 6:1997;249-266.
13. Feigin A., Kieburtz K., Bordwell K., Como P., Steinberg K., Sotack J., Zimmerman C., Hickey C., Orme C., Shoulson I. Functional decline in Huntington's disease. Mov. Disord. 10:1995;211-214.
14. Ferrante R. J., Kowall N. W., Cipolloni P. B., Storey F., Beal M. F. Excitotoxic lesions in primate as a model for Huntington's disease. Histopathologic and neurochemical characterization. Exp. Neurol. 119:1993;46-47.
15. Foroud T., Siemers E., Kleindorfer D., Bill D. J., Hodes M. E., Norton J. A., Conneally P. M., Christian J. C. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann. Neurol. 37:1995;657-664.
16. Furtado J. C. S., Mazurek M. F. Behavioral characterization of quinolinate-induced lesions of the medial striatum: relevance for Huntington's disease. Exp. Neurol. 138:1996;158-168.
17. Hedreen J. C., Folstein S. E. Early loss of neostriatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54:1995;105-120.
18. Jarrard L. E. On the role of the hippocampus in learning and memory in the rat. Behav. Neural Biol. 60:1993;9-26.
19. Lange K. W., Sahakian B. J., Quinn N. P., Marsden C. D., Robbins T. W. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J. Neurol., Neurosurg. Psychiatry. 58:1995;598-606.
20. Lawrence A. D., Sahakian B. J., Hodges J. R., Rosser A. E., Lange K. W., Robbins T. W. Executive and mnemonic functions in early Huntington's disease. Brain. 119:1996;1633-1645.
21. Levy R., Friedman H. R., Davachi L., Goldman-Rakic P. S. Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J. Neurosci. 17:1997;3870-3882.
22. Lindner M. D., Balch A. H., VanderMaelen C. P. Short forms of the "reference-" and "working-memory" Morris water maze for assessing age-related deficits. Behav. Neural Biol. 58:1992;94-102.
23. Marrannes R., Wauquier A. Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Pharmacol. Biochem. Behav. 31:1988;153-162.
24. Martin J. B., Gusella J. F. Huntington's disease: Pathogenesis and management. N. Engl. J. Med. 315:1986;1267-1276.
25. Massman P. J., Delis D. C., Butters N., Levin B. E., Salmon D. P. Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J. Clin. Exp. Neuropsychol. 12:1990;729-744.
26. Misztal M., Skangiel-Kramska J., Niewiadomska G., Danysz W. Subchronic intraventricular infusion of quinolinic acid produces working memory impairment - A model of progressive excitotoxicity. Neuropharmacology. 35:1996;449-458.
27. Roberts R. C., Ahn A., Swartz K. J., Beal M. F., Difiglia M. Intrastriatal injections of quinolinic acid or kainic acid: differential patterns of cell survival and the effects of data analysis on outcome. Exp. Neurol. 124:1993;274-282.
28. Sanberg P. R., Calderon S. F., Giordano M., Tew J. M., Norman A. B. The quinolinic acid model of Huntington's disease: Locomoter abnormalities. Exp. Neurol. 105:1989;45-53.
29. Schwarcz R., Whetsell W. O., Mangano R. M. Quinolinic acid: An endogenous metabolite that produces axon-sparing lesions in rat brain. Science. 219:1983;316-318.
30. Shiwach R. Psychopathology in Huntington's disease patients. Acta Psychiatrica Scandinavica. 90:1994;241-246.